Acorda Therapeutics Inc (ACOR)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Ronald Cohen
Employees:
474
420 SAW MILL RIVER ROAD, ARDSLEY, NY 10502
914-347-4300

Acorda Therapeutics, Inc. develops and markets therapeutic products for nervous system disorders. The company's two main products are Ampyra and Zanaflex Capsules. The Ampyra is an oral drug, which treats to improve walking in patients with multiple sclerosis and Zanaflex Capsules, which is a short acting drug for the management of spasticity, a symptom of many central nervous system disorders, including multiple sclerosis and spinal cord injury. Acorda Therapeutics was founded by Ronald Cohen in 1995 and is headquartered in Ardsley, NY.

Data derived from most recent annual or quarterly report
Market Cap 45.831 Million Shares Outstanding11.124 Million Avg 30-day Volume 94.231 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 8.66 / 3.27 Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from ACOR instead.

View recent insider trading info

Funds Holding ACOR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ACOR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CLEM KERRY M CHIEF COMMERCIAL OFFICER

  • Officer
11,594 2021-09-09 2

COHEN RON PRESIDENT AND CEO

  • Officer
  • Director
131,890 2021-09-03 2

SABELLA LAUREN M CHIEF COMMERCIAL OFFICER

  • Officer
12,221 2021-09-03 2

MORALES ROBERT INTERIM PAO & PFO

  • Officer
4,423 2021-09-03 2

PANEM SANDRA PHD

  • Director
10,000 2021-06-02 1

GREENE BARRY E

  • Director
10,000 2021-06-02 1

KELLEY JOHN P

  • Director
10,000 2021-06-02 1

RANDALL LORIN

  • Director
10,000 2021-06-02 1

JENSEN PEDER

  • Director
10,000 2021-06-02 1

STRADER CATHERINE D.

  • Director
10,000 2021-06-02 1

BLANK BURKHARD CMO AND HEAD OF R&D

  • Officer
18,527 2021-03-03 1

LAWRENCE DAVID CHIEF, BUS. OPS & PAO

  • Officer
13,811 2020-12-01 2

RAUSCHER STEVEN M

  • Director
0 2020-06-15 0

WASMAN JANE PRESIDENT, INTL AND GC

  • Officer
117,420 2019-12-02 0

HINDMAN ANDREW A. CHIEF BUSINESS OFFICER

  • Officer
15,639 2019-03-08 0

SCOPIA CAPITAL MANAGEMENT LP

SCOPIA MANAGEMENT, INC.

SIROVICH MATTHEW

MINDICH JEREMY

  • 10% Owner
No longer subject to file 2019-01-30 0

SMITH IAN F

  • Director
0 2018-06-27 0

BATYCKY RICHARD P. CHIEF TECH. OFF. & SITE HEAD

  • Officer
55,513 2018-02-22 0

BLIGHT ANDREW CHIEF SCIENTIFIC OFFICER

  • Officer
78,594 2017-03-01 0

ROGERS MICHAEL W CHIEF FINANCIAL OFFICER

  • Officer
0 2016-05-11 0

CARRAZANA ENRIQUE J. CHIEF MEDICAL OFFICER

  • Officer
32,148 2015-12-01 0

WESSEL THOMAS CHIEF MEDICAL OFFICER

  • Officer
36,350 2011-03-03 0

YOUNG WISE

  • Director
17,307 2010-06-09 0

PHILLIPS BARCLAY A

  • Director
308,801 2008-06-13 0

RIDGEBACK CAPITAL INVESTMENTS LTD.

RIDGEBACK CAPITAL MANAGEMENT LLC

HOLMAN WAYNE GEORGE

  • 10% Owner
No longer subject to file 2008-01-14 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MORALES ROBERT - Officer INTERIM PAO & PFO

2021-09-08 07:20:22 -0400 2021-09-03 F 448 $4.38 d 4,423 direct 2.765 7.1429 3.4562 10.3687 15 -5.9908 23

SABELLA LAUREN M - Officer CHIEF COMMERCIAL OFFICER

2021-09-08 07:21:30 -0400 2021-09-03 F 1,511 $4.38 d 12,221 direct 2.765 7.1429 3.4562 10.3687 15 -5.9908 23

COHEN RON - Director - Officer PRESIDENT AND CEO

2021-09-08 07:19:03 -0400 2021-09-03 F 3,940 $4.38 d 131,890 direct 2.765 7.1429 3.4562 10.3687 15 -5.9908 23

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ACORDA THERAPEUTICS INC ACOR 2021-10-25 22:15:03 UTC -17.3502 17.4202 100000
ACORDA THERAPEUTICS INC ACOR 2021-10-25 21:45:03 UTC -17.3502 17.4202 100000
ACORDA THERAPEUTICS INC ACOR 2021-10-25 21:15:03 UTC -17.3502 17.4202 100000
ACORDA THERAPEUTICS INC ACOR 2021-10-25 20:45:03 UTC -16.9966 17.0666 100000
ACORDA THERAPEUTICS INC ACOR 2021-10-25 20:15:03 UTC -16.9966 17.0666 100000
ACORDA THERAPEUTICS INC ACOR 2021-10-25 19:45:04 UTC -16.9966 17.0666 100000
ACORDA THERAPEUTICS INC ACOR 2021-10-25 19:15:03 UTC -16.9966 17.0666 100000
ACORDA THERAPEUTICS INC ACOR 2021-10-25 18:45:02 UTC -17.0065 17.0765 100000
ACORDA THERAPEUTICS INC ACOR 2021-10-25 18:15:03 UTC -17.0065 17.0765 100000
ACORDA THERAPEUTICS INC ACOR 2021-10-25 17:45:03 UTC -17.0065 17.0765 100000
ACORDA THERAPEUTICS INC ACOR 2021-10-25 17:15:03 UTC -17.0065 17.0765 100000
ACORDA THERAPEUTICS INC ACOR 2021-10-25 16:45:02 UTC -17.3815 17.4515 100000
ACORDA THERAPEUTICS INC ACOR 2021-10-25 16:15:03 UTC -17.3815 17.4515 25000
ACORDA THERAPEUTICS INC ACOR 2021-10-25 15:45:03 UTC -17.3815 17.4515 25000
ACORDA THERAPEUTICS INC ACOR 2021-10-25 15:15:03 UTC -17.3815 17.4515 25000
ACORDA THERAPEUTICS INC ACOR 2021-10-25 14:45:02 UTC -17.2845 17.3545 20000
ACORDA THERAPEUTICS INC ACOR 2021-10-25 14:15:03 UTC -17.2845 17.3545 20000
ACORDA THERAPEUTICS INC ACOR 2021-10-25 13:45:03 UTC -17.2845 17.3545 20000
ACORDA THERAPEUTICS INC ACOR 2021-10-25 13:15:03 UTC -17.2845 17.3545 20000
ACORDA THERAPEUTICS INC ACOR 2021-10-25 12:45:04 UTC -17.2845 17.3545 20000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Enhanced Index Plus Fund ACOR -46.0 shares, $-42.9 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund ACOR -76.0 shares, $-70.88 2020-03-31 N-PORT

Elevate your investments